A carregar...

Intravenous Immunomodulatory Nanoparticle Treatment for Traumatic Brain Injury

OBJECTIVE: There are currently no definitive disease-modifying therapies for traumatic brain injury (TBI). In this study, we present a strong therapeutic candidate for TBI, immunomodulatory nanoparticles (IMPs), which ablate a specific subset of hematogenous monocytes (hMos). We hypothesized that pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Neurol
Main Authors: Sharma, Sripadh, Ifergan, Igal, Kurz, Jonathan E., Linsenmeier, Robert A., Xu, Dan, Cooper, John G., Miller, Stephen D., Kessler, John A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7296512/
https://ncbi.nlm.nih.gov/pubmed/31925846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25675
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!